Free Trial
→ What to do with your collapsing portfolio… (From Brownstone Research) (Ad) Buy RLAY Stock  Free RLAY Stock Alerts

Relay Therapeutics (RLAY) SEC Filings & 10K Form

Relay Therapeutics logo
$2.69 +0.08 (+3.07%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.68 -0.02 (-0.56%)
As of 04/17/2025 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Relay Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/20/2025
5:13 PM		Point72 Asset Management, L.P. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G
02/26/2025
3:10 PM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
7:56 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
12:23 PM		BlackRock, Inc. (Filed by)
Relay Therapeutics (Subject)
Form SCHEDULE 13G/A
01/30/2025
8:02 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:06 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:10 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
8:16 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
6:01 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:03 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
3:04 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
8:00 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
8:00 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:30 AM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:35 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:05 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:01 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:18 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
6:00 AM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:07 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:08 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:09 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:05 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:45 PM		Relay Therapeutics (Filer)
Form 424B5
09/11/2024
3:49 PM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:43 PM		Relay Therapeutics (Filer)
Form 424B5
09/09/2024
7:00 AM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
4:23 PM		Relay Therapeutics (Filer)
Form S-3ASR
08/06/2024
3:15 PM		Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
5:42 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:42 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:43 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad)

Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so. Musk has been quietly creating one of the most ambitious AI ventures in history.

For all the details - including the name and ticker of our #1 AI stock to buy right now - click here
07/31/2024
3:06 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:37 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:24 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:29 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:47 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:05 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:15 PM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:38 PM		Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:41 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:43 PM		Patel Sanjiv (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:18 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2024
7:00 AM		Relay Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:01 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:02 PM		HILL LINDA A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM		Borisy Alexis (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:03 PM		INGRAM DOUGLAS S (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM		Kathiresan Sekar (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:04 PM		Relay Therapeutics (Issuer)
Rubin Jami (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM		Relay Therapeutics (Issuer)
Shawver Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:05 PM		Murcko Mark (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:12 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM		Relay Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
7:30 PM		Bergstrom Donald A (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:31 PM		Catinazzo Thomas (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:33 PM		Adams Brian (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:36 PM		Rahmer Peter (Reporting)
Relay Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
3:05 PM		Relay Therapeutics (Filer)
Form DEF 14A
04/23/2024
3:10 PM		Relay Therapeutics (Filer)
Form DEFA14A
04/23/2024
3:15 PM		Relay Therapeutics (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RLAY) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
Trump Orders 'National Digital Asset Stockpile'
‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more traction
Crypto 101 Media | Sponsored
‘Wheels Are Falling Off’ the U.S. Stock Market
The last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...
Stansberry Research | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored